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To conduct a systematic review to examine associations between hypoglycemia and quality
of life (QoL) in children and adolescents with type 1 diabetes.
Methods
Four databases (Medline, Cochrane Library, CINAHL, PsycINFO) were searched systemat-
ically in November 2019 and searches were updated in September 2021. Studies were eligi-
ble if they included children and/or adolescents with type 1 diabetes, reported on the
association between hypoglycemia and QoL (or related outcomes), had a quantitative
design, and were published in a peer-reviewed journal after 2000. A protocol was registered
the International Prospective Register of Systematic Reviews (PROSPERO;
CRD42020154023). Studies were evaluated using the Joanna Briggs Institute’s critical
appraisal tool. A narrative synthesis was conducted by outcome and hypoglycemia severity.
Results
In total, 27 studies met inclusion criteria. No hypoglycemia-specific measures of QoL were
identified. Evidence for an association between SH and (domains) of generic and diabetes-
specific QoL was too limited to draw conclusions, due to heterogenous definitions and oper-
ationalizations of hypoglycemia and outcomes across studies. SH was associated with
greater worry about hypoglycemia, but was not clearly associated with diabetes distress,
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depression, anxiety, disordered eating or posttraumatic stress disorder. Although limited,
some evidence suggests that more recent, more frequent, or more severe episodes of hypo-
glycemia may be associated with adverse outcomes and that the context in which hypogly-
cemia takes places might be important in relation to its impact.
Conclusions
There is insufficient evidence regarding the impact of hypoglycemia on QoL in children and
adolescents with type 1 diabetes at this stage. There is a need for further research to exam-
ine this relationship, ideally using hypoglycemia-specific QoL measures.
Introduction
Type 1 diabetes is one of the most common chronic conditions among children and adoles-
cents and requires a demanding treatment regimen (e.g., insulin administration several times
a day, monitoring of glucose levels and regulation of food intake and physical activity) [1, 2].
The goal of diabetes management is to achieve and maintain recommended glycemic levels to
prevent/delay acute and long-term complications [1]. However, treatment with insulin can
lead to hypoglycemia (low blood glucose level) [3]. Hypoglycemia can cause immediate
uncomfortable symptoms (e.g., shakiness, dizziness), and in severe cases lead to confusion, sei-
zures and coma, where self-treatment is not possible. In addition, recurrent episodes of severe
hypoglycemia (SH) have been associated with neurocognitive impairments, especially in
young children [4].
Although rates of SH in children and adolescents have decreased significantly in the past
two decades, due to improvements in insulin administration and monitoring technologies
(e.g., continuous subcutaneous insulin infusion and continuous glucose monitoring) [5–7], a
recent systematic review still reported an incidence of 1.21–30 events per 100 person-years in
young people with type 1 diabetes [8]. Hypoglycemia is particularly challenging and complex
to manage in children and adolescents with type 1 diabetes for several reasons: this group has
less predictable eating, activity, and sleep patterns relative to adults; children’s diabetes is often
(co-)managed by the parent; and young children may be unable to communicate their symp-
toms and needs [9]. Among adolescents, both hormonal changes leading to insulin resistance
[10] and developmental changes, such as seeking independence from parents, that add to the
burden of self-management, can lead to greater fluctuations in glucose levels and increase the
risk of hypoglycemia [11].
Another important goal of pediatric diabetes management is to achieve and maintain opti-
mal quality of life (QoL) [12]. While some studies have shown that hypoglycemia is negatively
associated with QoL [13, 14], other studies have not found such an association [15, 16].
Although QoL is defined and assessed in many different ways across studies, it is recognized
that QoL is a multidimensional, dynamic and subjective construct [17]. It has been argued
that, to understand the impact of a condition on QoL, we need to ask people how satisfied they
are with the areas of life that are important to them for their overall QoL, and then ask how
these areas are affected by the condition, such as diabetes or, more specifically, hypoglycemia
[18, 19]. It is therefore important to critically examine the range of patient-reported outcomes
(PROs) used in studies, and to determine which are measuring the impact on QoL, and which
are measuring related outcomes (such as diabetes-specific emotional distress or health status)
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rather than QoL [18]. Synthesis of the current evidence base is needed to determine the rela-
tionship between hypoglycemia and QoL-related outcomes.
Therefore, our aim was to conduct a systematic review to summarize and critically appraise
the evidence regarding the association between hypoglycemia and QoL (and related outcomes)
in children and adolescents with type 1 diabetes.
Methods
Search strategy
This review was conducted in accordance with the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines [20] and was registered on the International
Prospective Register of Systematic Reviews (PROSPERO; CRD42020154023) database. A sys-
tematic search of Medline, Cochrane Library, CINAHL and PsycINFO databases was con-
ducted in November 2019 and updated in September 2021, as part of a larger search strategy
for five related systematic reviews examining the impact of hypoglycemia in various popula-
tions. Search terms included free-text and subject heading terms relating to the following con-
cepts, separated by the Boolean operator “and”: (1) type 1 diabetes, (2) children and
adolescents, (3) hypoglycemia and (4) QoL and related outcomes. There were no limits applied
to date or language at the search stage. The search string is provided in S2 File.
Inclusion & exclusion criteria
Studies were eligible if they: (1) included children and/or adolescents with type 1 diabetes,
majority aged�18 years (or mean age<18 years old), (2) assessed the history of hypoglycemia,
(3) included outcomes of generic, diabetes-specific or hypoglycemia-specific QoL (or domains
of QoL) or related outcomes (e.g., fear of hypoglycemia, depression, diabetes distress), (4) exam-
ined the association between hypoglycemia and QoL or related outcomes, (5) had a quantitative
design, (6) were published in a peer-reviewed journal with full text available in English, (7) were
published after 2000. The focus was limited to publications in the past two decades, as diabetes
management strategies and rates of hypoglycemia have changed considerably in recent decades
[5–7]. Studies were excluded if they: (1) focused on cognitive functioning [21] or neurodevelop-
mental disorders [22], or (2) only included proxy-report (e.g., by parents) of outcomes [23].
Screening, article selection, and data extraction
Abstract screening was completed by three reviewers, with 10% of the abstracts being double
screened (AS, AC and MCL). MC completed full text-screening (with input from a second
reviewer (MB) where queries arose), and 10% of the full-text records were independently
screened by a third reviewer (KM). In case of disagreement, reviewers discussed until consen-
sus was reached. Additionally, forward chaining (i.e., citation searching of included studies in
Google Scholar) and backward chaining (i.e., reference list checking of all included studies)
was undertaken to identify additional eligible papers. Data extraction was performed by MC
and KS; extracted data included reference details, study details, participant characteristics,
analysis, results and discussion points. Extracted data were checked by two independent
reviewers (HC, MB) and consensus was reached in case of discrepancies.
Risk of bias assessment
Risk of bias was assessed (MC) by the analytical cross-sectional studies critical appraisal tool
from the Joanna Briggs Institute (JBI) [24]. Risk of bias assessment was not used to exclude stud-
ies but was discussed and summarized to aid interpretation of the quality of the evidence base.
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Data synthesis
Narrative synthesis was structured primarily by a conceptual framework of QoL (Table 1),
wherein outcomes were grouped based on two dimensions [18]: 1) the scope of the measure
(global, broad, specific): i.e. whether a questionnaire assesses global QoL (e.g., ‘overall QoL’), a
broad domain of QoL (e.g., social functioning) or a specific domain of QoL (e.g., friends); and
2) the attribution of the measure (generic, diabetes- or hypoglycemia-specific): generic QoL
measures ask people to rate areas of their life overall. These ratings can be affected by many
factors including but also unrelated to diabetes, whereas diabetes-specific [or hypoglycemia-
specific] QoL measures seek to attribute any impact to the condition, specifically asking: ‘how
does diabetes [or hypoglycemia] impact on your QoL?’
If a measure did not assess QoL but assessed a concept closely related to QoL (such as
depressive symptoms, diabetes distress, FoH), it was classified as a related outcome. Diabetes
distress refers to the negative emotions related to living with diabetes [25]. These related out-
comes were grouped by the attribution of the measure (generic, diabetes- or hypoglycemia-
specific outcome). Within each outcome group, study findings were summarized separately
for SH and non-severe hypoglycemia (NSH) according to the authors’ definitions, and where
possible by outcome type/questionnaire.
To enhance consistency and transparency in the narrative synthesis and to avoid vote
counting based on statistical significance [26], the following considerations were taken into
account to interpret the evidence per outcome: 1) whether definitions and recall periods of
hypoglycemia varied between studies; 2) whether there was a valid assessment of QoL and/or
related outcomes; 3) whether analyses were conducted for children and adolescents separately
or together; 4) whether there were exclusion criteria that directly related to hypoglycemia or
QoL outcomes; and 5) whether effect sizes were available: small (r�0.10 and<0.30), moderate
(r�0.30 and<0.50), and large r�0.50) [27].
It was determined that there was insufficient evidence to draw a conclusion for an outcome
if: a) there were less than three studies examining the association, or b) there was considerable
heterogeneity in definitions of hypoglycemia and sample characteristics across studies.
Results
Included studies
The searches yielded 1165 results. Title and abstract screening resulted in 217 potential includes.
After full-text screening, 17 studies were included. An overview of the full-text papers that have
been assessed for eligibility with reasons for exclusion is provided in S1 Table. Forward and
backward chaining yielded 10 extra includes. In total, 27 studies were included for data extrac-
tion and synthesis. Fig 1 provides an overview of the screening and selection process.
Study characteristics
The 27 studies included a total of N = 141,530 participants, with sample sizes ranging from
N = 39 to N = 2,602, with the exception of two large-scale studies (N = 53,986 and N = 75,258).
The studies were conducted in 18 countries, the majority conducted in USA (n = 6) and Ger-
many (n = 4). One study included multiple countries in Europe, North America and Japan
[37]. The age of participants ranged from 5–25 years. Most studies included participants
between 8–18 years, although eight studies also included participants above 18 years, and four
studies also included participants aged 5–7 years. One study included children aged 6–12 years
and five studies included adolescents aged 12–18 years. Study characteristics are detailed in
Table 2.
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All studies had a cross-sectional design. Assessment of hypoglycemia relied mostly on retro-
spective self-report (n = 19, 70%), with recall periods ranging from the past month (n = 4) to the
Table 1. Overview of quality of life and related outcomemeasures in the included studies, by breadth and attribution.
Quality of Life (QoL) and related
outcomes
Generic Diabetes-specific Hypoglycaemia-specific
(no attribution) (attribution to diabetes) (attribution to hypoglycaemia)
Global QoL • KINDL-R Total score [13] • DISABKIDS DCGM-12 [13,
28]
None
• PedsQL total score [16, 29–31] • DQOLY total score [32]
• DQOLY impact scale [32]
• DQOLY Diabetes life
satisfaction scale [32]






• KIDSCREEN 27: physical wellbeing [14] None None
• KINDL R: physical [13, 34]
• PedsQL: physical functioning [16, 31]
• EQ5D VAS scale [14]
Social
functioning
• PedsQL: social functioning [31] None None
• PedsQL: psychosocial functioning [16, 31]
Psychological
functioning
• KIDSCREEN 27: psychological well-being [14] None None
• KINDL R: emotional wellbeing [13, 34]
• PedsQL: emotional functioning [31]
• KIDSCREEN-10 index [14]
Specific domains of
QoL
Family • KINDL R: family [13, 34] None None
• KIDSCREEN 27: Autonomy and relationships
with parents [14]
Friends • KINDL R: friends [13, 34] None None
• KIDSCREEN 27: Relationships with friends or
peers [14]
School / Studies • PedsQL: school functioning [31] None None
• KINDL R: school [13, 34]
• KIDSCREEN 27: school [14]
Self-esteem • KINDL R: self-esteem [13, 34] None None




• Screen for Child Anxiety-Related Disorders [36] • DQOLY: Worries about
diabetes [32, 37]
• Hypoglycaemia Fear Survey–child
version (HFS-C) total scale
[15, 38, 39]• ICD-10 anxiety disorder diagnosis [40] • KINDL-R chronic illness scale
[34] • HFS-C ‘worries about
hypoglycaemia’ subscale
[36, 38, 41, 42]
• PedsQL DM: diabetes distress
[15, 29, 30, 42, 45, 46]
• State-Trait Anxiety Inventory for Children,
Trait Subscale [38]
• HFS-C ‘fear of hypoglycaemia
related behaviors’[36, 38, 41]
• PedsQL DM: ‘diabetes
symptoms’ [42]
• Child Posttraumatic Stress
• PedsQL DM: ‘diabetes
management’ [42]
• Reaction Index (hypoglycaemia is
referred to as the traumatic event)
[47]
• Center for Epidemiological Studies-Depression
Scale [43, 44]
• DISABKIDS impact scale
[13, 28] • Child Hypoglycaemia Index-2 [44]
• Children’s Depression Inventory, Short version
[48]
• Diabetes Eating Problem
Survey-Revised [50]
• Adolescents–IV (DSM IV depression diagnosis)
[49]
https://doi.org/10.1371/journal.pone.0260896.t001
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past three (n = 5), six (n = 5) or 12 months (n = 7), to period since diagnosis (n = 1). Hypoglyce-
mia was reported by the child or adolescent with diabetes (n = 10, 34%), their parent(s) (n = 7,
24%), or both (n = 1, 4%); or based on a combination of self-report and glucose meter data
(n = 2, 8%). Six studies (22%) focused on hypoglycemia that involved coma or seizures, assessed
via medical records. Two studies (7%) did not specify how hypoglycemia data were derived.
Twenty-one studies (78%) examined SH, defined as episodes: 1) where assistance of others
was needed (n = 4); 2) resulting in confusion or seizures/coma (n = 7), or 3) characterized by a
combination of these definitions (n = 8). Four studies did not specify a definition of SH. Ten
studies (37%) examined “moderate” hypoglycemia, which will be referred to as “non-severe”
hypoglycemia (NSH) throughout this review. Although it is recognized that NSH is usually
referred to as “self-treated” hypoglycemia [51], that is not appropriate when describing hypo-
glycemia in (younger) children, as their parents often need to help regardless of the severity of
the episode. Twelve studies (44%) used a continuous measurement of hypoglycemia (e.g., fre-
quency of SH in the past 6 months), and fifteen (55%) reported on categorical measurement of
hypoglycemia (e.g., absence or presence of SH).
The studies included 19 instruments to assess QoL and related outcomes (Table 1). The
most commonly used were the Hypoglycemia Fear Survey Child Version (HFS-C) (n = 6) and
the Pediatric Quality of Life Inventory (PedsQL) Generic (n = 4) and Diabetes (n = 6) modules.
An overview of all scales being used in the studies can be found in S2 Table.
Risk of bias assessment
Of the 27 studies, 93% included participants with a medically-verified diagnosis of type 1 dia-
betes. Most provided adequate details of their inclusion and exclusion criteria (89%) and
Fig 1. PRISMA flowchart of the systematic search and screening, reasons for exclusions, and final number of
included studies.
https://doi.org/10.1371/journal.pone.0260896.g001
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participants and settings (74%). In 52% of the studies, hypoglycemia was defined in accor-
dance with the current International Society for Pediatric and Adolescent Diabetes (ISPAD)
definition; namely, SH as an event with severe cognitive impairment (including coma and sei-
zures) requiring assistance by others, and NSH as events with a blood glucose value�3.9
mmol/L (70 mg/dL) [52]. Most studies (81%) used statistical analyses appropriate to their data
and, while all studies identified confounding factors, 67% adjusted analyses accordingly. Most
studies (70%) used psychosocial outcome measures that were psychometrically valid and reli-
able instruments for use with children and adolescents with type 1 diabetes. In 11% of the stud-
ies, both validated and non-validated measures [13, 28, 36] were used, while 19% included
measures that were not validated in adolescents with type 1 diabetes [14, 34, 35, 43, 47]. A full
overview of the risk of bias assessment is presented in S3 Table.
Narrative synthesis
Table 3 provides a summary of the main findings of each study.
Global QoL. Table 1 shows that both generic measures and diabetes-specific measures of
global QoL were used. One study used a non-validated questionnaire [13]. The age of the par-
ticipants in these studies ranged from 11–21 years, and one study conducted analysis for chil-
dren and adolescents separately [30].
Severe hypoglycemia. Three studies examined the relationship between SH and generic QoL
using the KINDL-R [13] or the PedsQL [30, 31]. One study showed that those with SH (not
further defined) in the past month reported significantly lower QoL than those without SH,
but this was not observed for SH in the past year [13]. Two studies found no significant differ-
ences in generic QoL between groups with and without SH (not further defined [30] or epi-
sodes requiring assistance from others [31]) in the past 6 [31] to 12 months [30].
Three studies explored the association between SH and diabetes-specific QoL using the DIS-
ABKIDS DCGM-12 [13, 28] or the DQOL-Y [33]. In two studies, SH (not defined [13] or epi-
sodes requiring assistance [28]) in the past 12 months was not associated with diabetes-specific
QoL after adjustment for covariates (e.g., age, gender, HbA1c). However, one of these studies
indicated that those who experienced SH (not further defined) in the past month reported signif-
icantly lower diabetes-specific QoL than those who had not [13]. The third study found that SH
with coma since diagnosis was significantly associated with lower diabetes-specific QoL [33].
Non-severe hypoglycemia. One study found no significant differences diabetes-specific QoL
scores on the DQOL-Y, between those who experienced NSH (glucose levels below 70 mg/dl)
in the past three months and those who did not [32].
Two studies reported no significant association between frequency of NSH (glucose levels
below 60 or 70 mg/dl) in the past month and generic QoL (PedsQL) after adjusting for covari-
ates such as gender, hyperglycemia and age of onset of diabetes [16, 29].
Broad and specific domains of QoL. Table 1 shows that studies examined three broad
domains of QoL (psychological, physical, or social functioning), and/or the following specific
domains of QoL: school, family, friends, self-esteem and sleep. Three studies used non-vali-
dated QoL questionnaires [13, 14, 34]. The participants’ age range was 8–21 years, one study
only included adolescents aged 12–18 [35].
Severe hypoglycemia. Four studies examined the relationship between SH (not further
defined [13], or inability to self-treat due to neurological dysfunction [14, 34] or requiring
assistance from others [31]) and broad domains (physical, psychological, social), or specific
domains (self-esteem, family, friends or school) of QoL.
Three studies found no significant relationship between SH in the past 1–12 month(s) and
physical functioning, [13, 14, 34]. In contrast, one study indicated that those with two or more
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PLOSONE | https://doi.org/10.1371/journal.pone.0260896 December 2, 2021 10 / 25







QoL domain or related
outcome
Instrument Findings: Association between




Nocturnal H: BG levels<70 mg/dL or
symptomatic H
No. nocturnal H
episodes; self or parent
reported




Frequency of trouble with H episodes
Passed out due to H H episode while
asleep H episode while you were
awake but by yourself H in front of
friends or strangers? H when you
were at school?
Categorical (1–2, 3–6,
7–11,>11) and yes vs.
no; self-reported






HFS -C SCARED 1Pass out due to H associated with H
related behaviors (β = 0.502���),
separation (β = 0.189��) and school
anxiety (β = -0.271���) H while asleep
associated with worries about H (β =
-0,508��) GAD (β = -0.253, p��) and
separation anxiety (β = -0.274��) H
while awake associated with H related
behaviors (β = -0.300�), worries about
H (β = -0.508��), panic disorder (β =
-0.318���), GAD (β = -0.206��) and
social anxiety (β = -0.388���) H in
front of friends associated with panic
disorder (β = 0.595���), GAD (β =
0.537���), separation anxiety (β =
0.321��), social anxiety (β = 0.362��)
and school anxiety (β = 0.303���). H at
school associated with H related
behaviors (β = -0.312�), panic disorder
(β = -0.284���), GAD (β = -0.177�),
separation anxiety (β = -0.232��) and
social anxiety (β = -0.367���) All other
associations are N.S. Covariates: age,
gender, education, exercise, treatment
type, duration of T1D, HbA1c, passing
out due to H, H as a big problem, H in




SH: H with unconsciousness or
consciousness but needing parent’s
help for treatment due to mental
confusion and disorientation
No. of SH episodes;
parent-reported
3 FoHWorries about H H
related behaviors




NSH: BG levels< 70 mg/dL, without
seizures or coma








PedsQL N.S. for psychosocial functioning,




SH: H when your blood glucose was
so low that you were unable to
recognize symptoms, ask for help, or
treat yourself due to mental confusion
or unconsciousness NSH: H when
your blood glucose was so low that it
interfered with what you were doing,
and you had to wait a while to recover
No. of SH and NSH
episodes; Self-reported





" SH associated with " worries about
H�� (r = 0.32) N.S. for NSH and
worries about H (r = 0.17, p>0.05) N.
S. for SH and NSH and diabetes
distress, diabetes symptoms, or
diabetes management (p>.05).
Covariates include age, gender, HbA1c,
frequencies of H, perceived severity of


























































































QoL domain or related
outcome
Instrument Findings: Association between





NSH: BG levels< 70 mg/dL No/several times a
month vs. Several times
a week/every day; self-
reported
NR DD PedsQL- DM N.S. for DD (p>0.05) Covariates:






SH: loss of consciousness or seizure or
requiring assistance from another
person to actively administer
carbohydrates, glucagon, or
intravenous glucose)
No. of SH episodes NR Anxiety disorders ICD-10 German
Modification
N.S. for rates of hypoglycaemia per
100 patient years between those with
and without anxiety disorders
(p>0.05) Covariates: age, sex, diabetes
duration, migratory background, type






NSH: BG so low that it interfered with
the adolescent’s ability to function,
but did not become so mentally
disoriented that self-treatment was
not possible SH: BG resulting in
neuroglycopenia that interfered with
the adolescent’s ability to self-treat
due to mental disorientation,
unconsciousness, or seizure H in
situations where the parent was not
present (e.g., while sleeping, alone, at
school, and in social situations)
No. of H episodes
(severe and moderate);
parent-reported
12 FoHWorries about H H
related behaviors Trait Anxiety
HFS C STAIC SH with unconsciousness " FoH vs. no
SH with unconsciousness� " SH
associated with " worries about H��
and FoH�� Only for girls after
adjustment for gender (Total: r = .59�;
Worries: r = .55�) "H episodes in
social situations associated with " trait
anxiety (r = 0.37�) " SH associated
with " FoH and " worries about H��
N.S. for SH and H related behaviors or
trait anxiety (data NR) N.S. for H and
FoH, worries about H, H related
behaviors and trait anxiety (data NR)
Covariates: trait anxiety scores
frequency of H over the past year
frequency of H, SH, episodes in





SH: needing assistance from another
person
No SH vs. SH; self-
reported




N.S. differences for diabetes-specific
QoL and DD (data NR) Covariates:
gender, age, duration, HbA1c,
frequency of BG tests, parents living
together or not, mother’s educational
level, use of insulin pump and center
SH only associated with # diabetes-
specific QoL in single parent families,
for adolescents (B = -1.22�) and
children (B = -0.92�)
Hassan et al.
(2017) [33]
SH with or without coma SH with coma vs. SH
without coma); taken
from the medical record
NR Diabetes-specific QoL DQOL-Y SH with coma vs. without coma




SH: seizures or unconsciousness No SH vs. �1 SH; self-
reported
3 Worries about diabetes DQOL-Y �1SH associated with " worries about


























































































QoL domain or related
outcome
Instrument Findings: Association between




SH: event resulting in a seizure or
coma




NR DD FoH PedsQL-DM
HFS-C
N.S. for DD or FoH (p>0.05)
Covariates: age and diabetes duration
Jurgen et al.
(2020) [44]




NSH: BG levels< 60 mg/dL without
seizures or coma
No. of NSH episodes;
parent-reported
1 General QoL DD PedsQL
PedsQL-DM
N.S. for general QoL or DD (p>0.05)
Covariates: gender, age of onset





SH: event requiring assistance of
another person
No SH vs. 1 SH No SH
vs.� 2 SH; parent-
reported
6 DD PedsQL-DM � 2SH vs. no SH associated with "
DD�� N.S. difference in no SH vs. 1
SH and DD (p>0.05)
Matziou et al.
(2010) [32]
NSH: BG values<3.9 mmol/L (70
mg/ dL)
No NSH vs. �1 H; self-
reported
3 Life satisfaction; disease
impact; disease related worries;
diabetes- specific QoL
DQOLY N.S. for diabetes life satisfaction,




SH: BG levels<60 mg/dl with
decreased level of consciousness
requiring glucagon or the help of
others
No SH vs. SH; taken
from medical record









SH vs. no SH associated with # general







SH: event requiring assistance of
another person
No SH vs. 1 SH No SH
vs.�2 SH; self-reported
6 Overall generic QoL;
psychosocial; social; school;
physical health; emotional
PedsQL � 2 SH vs. no SH associated with #
physical health (β = -4.00���) N.S. for
physical health between those with 1
SH vs. no SH and between those with
1 or�2 SH vs. no SH on general-QoL,
social functioning, school functioning,
emotional functioning and
psychosocial functioning (p>0.05)
Covariates: sex, race/ethnicity, age,
highest level of parent education, and
type of health insurance, BMI z score,
duration of diabetes, type of diabetes
treatment, HbA1c level, number of
comorbid conditions, emergency
department visits, and hospitalizations
in the preceding 6 months
Nip et al.
(2019) [50]
SH: event requiring assistance of
another person
No. of SH; self-reported 6 Overall eating behavior DEPS-R N.S. difference in frequency of SH




SH with need of assistance of other
persons, defined by unconsciousness,
seizures, or application of glucagon or
intravenous glucose
Rate of SH/patient year,
rate of SH coma/patient









SH /patient year " in those with
depression vs. without depression��N.
S. for SH coma/patient year (p>0.05)
Riaz et al.
(2017) [43]
SH and hospitalizations due to H No SH vs. SH No
hospitalization due to H
vs. hospitalizations due
to H



























































































QoL domain or related
outcome
Instrument Findings: Association between





N/A No SH vs. SH; parent-
reported
12 General QoL and DD PedsQL
PedsQL-DM
SH vs. NO SH associated with " DD (r




SH (N/A) SH episodes requiring
medical attention and NSH: % of
readings<70 mg/dl
No. of SH episodes;
Parent-reported
12 Helplessness; avoidance;
maintaining high BG; social
consequences
HFS C " SH associated with " helplessness
(r = 0.19��) N.S. for SH and
maintaining high BG, avoidance and
worry about negative social
consequences (data NR) Those who
needed medical attention due to H vs.
those without reported # avoidance�
N.S. for medical attention due to H
and helplessness, maintain high BG
and worry about negative social
consequences (data NR) Children
scoring in the highest tertile vs. the
lowest tertile of maintain high BG had
" SH episodes� N.S. for SH episodes,
medical treatment due to H and % of
readings<70 mg/dl and avoidance
(p>0.05) and for medical treatment
due to H and % of readings <70 mg/dl




NSH: BG levels<60mg/dl SH: H plus
one of the following: BG levels�30
mg/dl, loss of consciousness,
requirement of glucagon injection
parenteral treatment at hospital
No. of SH; taken from
BG charts and patients’
home notes
1 PTSD CPTS-RI " SH associated with " PTSD (ß =
0.450�) N.S. for any SH and PTSD
(data NR) N.S. difference in SH in last
month or any SH between those with





N/A No SH vs. SH in past 12
months No SH vs. SH in
past month; self-
reported
12 Physical wellbeing; emotional
wellbeing; self-esteem; family;






SH past year vs. no SH associated with
# quality of relationship friends (β =
-3.1�) SH past month vs. no SH
associated with # emotional wellbeing
(β = -4.2��), # school functioning (β =
-4.1�), # general QoL (β = -3.0��), #
diabetes-specific QoL(β = -4.5��) #
diabetes impact (β = -3.8�) and #
diabetes treatment (β = -6.6��) N.S.
association for SH past year or month
vs. no SH and physical wellbeing, self-
esteem, relationship with family
(p>0.05) N.S. for SH past year and
school functioning, diabetes-specific
QoL, diabetes impact and diabetes
treatment, general QoL emotional
wellbeing (p>0.05) N.S. for SH past
month and relationship with friends
(p>0.05) Covariates: sex, age group,
socioeconomic status, family structure,
HbA1c level, insulin regimen,
treatment satisfaction, weight status,


























































































QoL domain or related
outcome
Instrument Findings: Association between





SH: resulting in seizure or coma SH without seizure vs.









SH: episodes with severe neurological
dysfunction (e.g. seizures, loss of
consciousness, disorientation,
inability to arouse from sleep) that
require intervention with glucagon or
intravenous dextrose or milder forms
of hypoglycaemia associated with
neurological dysfunction that were
not recognized or self-treated
No. of SH episodes NR Physical; psychological;
wellbeing; self-esteem; family;
friends; school, illness related
distress
KINDL-R N.S. for physical wellbeing,
psychological wellbeing, self-esteem,
family, friends, school and illness
related distress (data NR) Covariates:
age and gender
ASWS, Adolescent Sleep Wake Scale; CDI-S, Children’s Depression Inventory, Short version; CES-D, Center for Epidemiological Studies-Depression Scale; CHI-2, Child Hypoglycemia Index 2;
CPTS-RI, Child Posttraumatic Stress Reaction Index, DEPS-R, Diabetes Eating Problem Survey-Revised; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders; DQOLY, Diabetes Quality
of Life for Youth scale; EQ-5D, EuroQoL 5 Dimensions; HFS-C, Hypoglycemia Fear Survey-Children version; ICD-10, International Classification of Diseases -10, PedsQL, Pediatric Quality of Life
Inventory; PedsQL-DM, Pediatric Quality of Life Inventory-Diabetes Module; SCARED, Screen for Child Anxiety Related Emotional Disorders; STAIC, State-Trait Anxiety Inventory for Children.
BG, blood glucose; DD, diabetes distress; FoH, fear of hypoglycemia; H, hypoglycemia; SH, severe hypoglycemia; No., number; N.S., Not significant (p>0.05); PTSD, Post-Traumatic Stress
Disorder; QoL, quality of life, sig., significantly.






















































































episodes of SH in the past six months reported significantly lower physical functioning than
those without SH, but not for those who only had one SH [31].
Three studies found no significant relationship between SH in the past six [31] to 12
months and psychological functioning [13, 31, 34]. However, one study examined various
recall periods and found that SH in the past month was significantly associated with lower psy-
chological functioning [13]. The fourth study reported that those with SH in the past three
months reported significantly lower psychological functioning than those without [14]. Two
studies examined the association between in the past 1–12 months and self-esteem and found
no significant results [13, 34].
One study reported no significant associations between SH in the past six months and social
functioning [31]. Three studies reported no significant associations between SH in the past
1–12 months and relationships with family [13, 14, 34]. None of the studies reported a signifi-
cant association between SH in the past 3–12 months and school [13, 14, 31, 34], although one
study indicated that SH in the past month was significantly associated with lower school func-
tioning [13]. Three studies examined the association between SH and quality of friendship [13,
14, 34]. One found that SH in the past year was significantly associated with lower quality of
friendship, but this was not observed for SH in the past month [13]. Two studies found no sig-
nificant association between SH and quality of friendship in the past 3–12 months [14, 34].
Non-severe hypoglycemia. Two studies examined associations of NSH and domains of QoL
using the PedsQL [16] or the ASWS [35]. The first study found no significant associations
between NSH (glucose levels below 70 mg/dl) in the past month and physical functioning or
psychosocial functioning [16]. The second study found no association between nocturnal
hypoglycemia (glucose levels below 70 mg/dl or symptomatic hypoglycemia) in the past
month and adolescents’ sleep quality [35].
Related outcomes-hypoglycemia-specific. Table 1 shows that although hypoglycemia-
specific QoL was not assessed, related outcomes were assessed, including fear of hypoglycemia
(FoH), and hypoglycemia-specific post-traumatic stress symptoms. One study used a non-vali-
dated questionnaire [47]. The participants’ age range was 6–20 years. Three studies specifically
focused on adolescents aged 12–18 [36, 38, 42] and one on children aged 6–12 [39].
Severe hypoglycemia. Seven studies examined the association between SH and FoH mea-
sured with the HFS-C [15, 36, 38, 39, 41, 42] or the CHI-2 [44].
Four studies examined relationships between SH and worries about hypoglycemia [36, 38, 41,
42] Three of these studies reported significant, small-to-medium, positive correlations between
frequency of SH (not further defined [41] or inability to self-treat due to mental disorientation or
seizures [38, 42]) in the past 12 months and greater worries about hypoglycemia. However, in one
study, this only remained statistically significant for female adolescents after controlling for gender
[38]. The fourth study found no significant difference in worries about hypoglycemia between
adolescents who never lost consciousness and those who ever lost consciousness due to SH, after
controlling for covariates such as age gender and other types of hypoglycemia [36].
Three of the studies also explored associations between SH and FoH related behaviors [36, 38,
41]. One study reported no significant association between frequencies of SH episodes (inability
to self-treat due to mental disorientation or seizures) and FoH related behaviors [38]. The second
study indicated that those who had passed out due to hypoglycemia significantly reported more
hypoglycemia related avoidance behaviors compared to those who had never passed out [36]. In
contrast, the third study reported that those who needed medical attention due to SH reported sig-
nificantly less hypoglycemia related avoidance behaviors than those who did not [41].
Three of the eight studies examined associations between SH (inability to treat due to men-
tal confusion or unconsciousness in the past three months [39] or SH resulting in seizures or
coma [15, 44]) and overall FoH, but found no significant associations [15, 39, 44].
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An additional study found that frequency of SH (loss of consciousness or requirement of
glucagon) in the past month was a significant predictor of self-reported post-traumatic stress
(PTSD) assessed with the CPTS-RI after adjustment for age and family history of diabetes [47].
Non-severe hypoglycemia. Four studies explored the relationship between NSH and HFS-C
subscale scores [36, 38, 41, 42]. Three of these studies reported no significant associations
between frequency of NSH (glucose values below 70 mg/dl [41] or interfering with ability to
function [38, 42]) and FoH. The fourth study found that frequency of NSH and ‘hypoglycemia
while at school’, ‘awake’ or ‘asleep’ were significantly associated with at least one of the HFS-C
scales, after adjustment for clinical factors and other types of hypoglycemia (e.g., passing out
because of hypoglycemia). This was not observed for ‘hypoglycemia in front of friends’ [36].
Related outcomes—diabetes-specific. Table 1 shows that studies assessed the relation-
ship between hypoglycemia worries attributed to diabetes, diabetes-related disordered eating
and diabetes distress. One study used a non-validated questionnaire [34]. The participants’ age
range was 5–21 years. Two studies focused on adolescents aged 12–18 [30, 42] and one study
conducted analysis for children and adolescents separately [28].
Severe hypoglycemia. Eight studies investigated the association between SH and diabetes
distress [13, 15, 28, 30, 34, 37, 42, 45]. Four of these studies used the PedsQL DM [15, 30, 42,
45]. One of these reported that SH (not further specified) in the past 12 months was signifi-
cantly associated with higher diabetes distress, compared to those without SH, with a small
effect size [30]. This was confirmed for those who experienced two or more SH episodes
(requiring assistance from others) in the past six months, but not for only one SH [45]. In con-
trast the other two studies reported no significant association between SH (inability to self-
treat due to mental confusion) in the past 12 months) [42] or SH (resulting in seizure or coma)
since diagnosis [15] and diabetes distress.
Two of the studies using the DISABKIDS Diabetes Module found a significant association
between SH (not further defined [13] or requiring assistance from others [28]) and greater dia-
betes distress if hypoglycemia was experienced in the past month [13] but not in the past year
[13, 28]. One study reported no significant association between SH (inability to self-treat due
to neurological dysfunction) and illness-related distress using the KINDL-R [34].
An additional study (using the DQOL-Y) reported that those who had SH involving sei-
zures or coma in the past three months reported significantly more worries about diabetes
than those without [37].
In addition, in one study frequency of SH (requiring assistance from others) in the past 6
months did not significantly differ between those with and without disordered eating mea-
sured with the DEPS-R [50].
Non-severe hypoglycemia. Four studies examined the association between NSH (glucose con-
centrations below 60 or 70 mg/dl [29, 32, 46] or interfering with ability to function [42]) in the
past 1–6 months and diabetes distress using the PedsQL DM [29, 42, 46] or the DQOL-Y [32].
None of these studies reported a significant association between NSH and diabetes distress.
Related outcomes–generic. Table 1 shows that generic outcomes including anxiety or
depression symptoms, or diagnosis were examined in the studies. Some of the studies used
measures that are not validated in young people with diabetes [36, 38, 43, 44]. The participants’
age range was 0–25 years.
Severe hypoglycemia. Three studies reported no significant association between SH and
depressive symptoms; the first explored the association between SH in the past 6 months (not
further defined) and CDI-S scores [48] and the other two explored the association between SH
resulting in coma or seizure and CES-D scores [43, 44]. In contrast, another study reported a
significant positive relationship between SH (requiring assistance from others and unconscious-
ness or application of glucagon) in the past year and a DSM-IV depression diagnosis [49].
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Two studies investigated the associations between SH and anxiety symptoms assessed by
the SCARED [36] or an ICD-10 anxiety disorder diagnosis [40]. The first study reported that a
history of passing out due to SH was significantly associated with greater symptoms of separa-
tion anxiety and school avoidance, but not with panic disorder, generalized anxiety or social
anxiety [36]. The second study reported no significant associations between SH (loss of con-
sciousness) and diagnosis of anxiety disorders [40].
Non-severe hypoglycemia. Two studies examining associations between hypoglycemia in
different situations and various anxiety types (using the SCARED [36] or STAIC [38]) found
that having ‘hypoglycemia while at school’, ‘in front of strangers’, ‘while awake’ or ‘asleep’ [36]
was significantly associated with greater symptoms anxiety, for example social anxiety or sepa-
ration anxiety [36] and that hypoglycemia in social situations was significantly associated with
higher trait anxiety, with a moderate effect size [38].
Discussion
To our knowledge, this is the first systematic review that critically examines evidence on the rela-
tionship between hypoglycemia and QoL and related outcomes among children and adolescents
with type 1 diabetes. Results of this review show that evidence regarding an association between
SH and (domains of) generic QoL is inconclusive, while the evidence suggests no association
between NSH and generic QoL. For diabetes-specific QoL, the evidence was too limited to draw
conclusions. None of the studies used hypoglycemia-specific QoLmeasures to explore the associa-
tion between hypoglycemia and QoL. In addition, there was some evidence suggesting an associa-
tion between SH in the past 12 months and greater worries about hypoglycemia, and no
association between NSH and diabetes distress. There was insufficient evidence to draw conclu-
sions regarding the relationship between hypoglycemia and diabetes distress (for SH), FoHworries
(for NSH), FoH-related behaviors and total FoH, anxiety, depression, disordered eating and PTSD.
A possible explanation for inconsistent findings is the heterogeneity in definitions of and
recall periods for hypoglycemia and measures used to assess QoL across studies. This variation
limits the ability to compare studies and draw conclusions. Several key limitations of the exist-
ing evidence base were identified, such as cross-sectional designs, low statistical power, lack of
reporting of effect sizes (and thus limited information on the clinical value of the observed sta-
tistically significant differences), lack of information on the definition or frequency of hypogly-
cemia, and the self-report of hypoglycemia over several months or even back to diagnosis,
which might have led to recall bias. The key recommendation for future studies is to use a defi-
nition of hypoglycemia as recommended by current guidelines. Future studies should also use
longitudinal /prospective study designs and modern methods, such as continuous glucose
monitoring, for a more objective assessment of hypoglycemia that does not rely on recall of
episodes, to determine the direct, day-to-day impact of hypoglycemia on various domains of
QoL in children and adolescents with type 1 diabetes.
Although the current evidence suggests no clear association between hypoglycemia and
some outcomes, it is important to note that studies were more likely to show statistically signif-
icant associations between hypoglycemia and outcomes when SH was experienced recently (in
the past 1–3 months), more frequently, or when it involved convulsions, unconsciousness, or
coma. In addition, some studies suggested that the context in which hypoglycemia takes places
(e.g., in social situations) might have implications for its impact. However, this was only based
on a few studies, some of which have methodological limitations. Thus, more evidence is
needed to confirm these associations.
Although emerging evidence shows the importance of self-treated hypoglycemia in relation
to QoL and related outcomes in adults with diabetes (50, 51), current evidence on this
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relationship in youth with type 1 diabetes suggested no association between NSH and QoL.
However, this should be interpreted with caution, as these studies are limited by the use of
generic and diabetes-specific QoL questionnaires, while hypoglycemia-specific QoL measures
may be more sensitive to the impact of NSH. Different research designs, that minimize recall
bias and assess the impact closer to the occurrence NSH are needed to understand the associa-
tion between NSH and QoL. In addition, this review identified only one study that explored
the association between hypoglycemia while asleep and sleep quality (28). This highlights the
need for more studies that investigate such relationships.
Although QoL has been considered as a key outcome in pediatric diabetes care [12], only
two studies had a primary aim to examine the impact of hypoglycemia on QoL [15, 42]. Fifteen
of the 27 studies aimed to explore QoL, however, only seven of these studies included measures
that actually assess QoL, whereas the others focused on particular domains of QoL or measured
related outcomes such as diabetes distress [13, 15, 28, 30, 34, 37, 42, 45] or health status [14],
rather than QoL. Even though other studies included in this review have focused on identifying
sociodemographic and clinical factors that are associated with QoL, it is difficult to identify the
impact of hypoglycemia specifically in these studies [13, 14, 16, 28, 30–34, 37, 45, 46]. Impor-
tantly, some of the studies that explored the impact of hypoglycemia on QoL as a secondary aim
had very low rates of hypoglycemia in their samples. To truly understand the impact of hypogly-
cemia on QoL, a questionnaire that assesses how hypoglycemia affects domains of life that are
important to the individual should be used [18]. Given that there are currently no hypoglyce-
mia-specific QoL measures that are designed to assess the impact of hypoglycemia on QoL in
children and adolescents with type 1 diabetes, these need to be developed and would need to be
age appropriate and to incorporate specific domains that are important to young people with
diabetes. There might be other domains of importance to young people’s QoL, such as leisure
activities, that were not included in questionnaires used in current studies.
Finally, the majority of studies included in this review pooled children and adolescents
together when examining the link between hypoglycemia and QoL or related outcomes.
Although these studies usually included age-appropriate assessments of outcomes, the impact
of hypoglycemia on these outcomes might be different for children and adolescents. While
younger children often rely on their parents for decisions about diabetes management, these
responsibilities are usually transferred to the child during adolescence [53, 54]. During this
challenging process of transferring responsibilities, the burden of self-management for the
adolescents increases and can lead to increased hypoglycemia, which can interfere with other
demands and lead to family conflicts, reduced self-efficacy and increased FoH, all aspects that
can compromise QoL in adolescents with diabetes [42, 55]. Future studies should thus explore
if the relationship between hypoglycemia and QoL is different in different age groups. Addi-
tionally, adolescence is characterized by a strong desire to be accepted by peers [54]. Episodes
of hypoglycemia in this age group could be experienced as embarrassing and mark out adoles-
cents with diabetes as different. Hypoglycemia has indeed previously been associated with
higher stigma in young people with diabetes [56], which can lead to poorer psychosocial and
medical outcomes [57]. Future studies need to explore the role of stigma as a possible mecha-
nism by which hypoglycemia impacts on QoL.
Strengths and limitations
Strengths of this review include the systematic and comprehensive search of multiple data-
bases, and the application of a conceptual framework of QoL to categorize outcome measures
in order to critically appraise the evidence. This allows for a more detailed understanding of
the various ways in which hypoglycemia can impact on QoL and related outcomes and
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highlights the gaps in the evidence base. This review also has some limitations. Although the
inclusion of a wide range of outcomes provided an overview of all the available evidence
related to the impact of hypoglycemia on QoL, it also made it difficult to compare studies
directly. Further, the heterogeneity across studies and the lack of effect sizes reported in stud-
ies, precluded the possibility of meta-analysis. The inclusion of only quantitative studies that
were published in English may have introduced some bias, although only six studies were
excluded for this reason.
Implications for clinical practice
The implications for clinical practice that can be drawn from this review are limited due to the
inconclusive and relatively small evidence-base. However, some evidence suggests that more
recent episodes of hypoglycemia might have an impact on various outcomes. This may be use-
ful for clinicians, as they could ask specifically about hypoglycemia and its impact in the
weeks/months following episodes of SH.
Conclusion
This systematic review shows that there is insufficient evidence on the relationship between
hypoglycemia and (domains of) generic and diabetes-specific QoL in children and adolescents
with type 1 diabetes. This is largely because heterogeneity and methodological limitations
across studies hamper the ability to draw strong conclusions. Importantly, none of the studies
used a measure designed specifically to assess the impact of hypoglycemia on QoL. Addition-
ally, there seems to be an association between SH and greater worry about hypoglycemia,
while the evidence is too limited for other related outcomes. Although limited, some evidence
suggests that issues such as timing and context of hypoglycemia might influence its impact.
Future research should focus on the development of measures that can assess the impact of
hypoglycemia in children and adolescents with type 1 diabetes and use agreed definitions of
hypoglycemia that increase comparability between studies.
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